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THE FOCUS OF THIS WORK is to improve understanding of the pathophysiology for decompression sickness (DCS). DCS is a systemic pathophysiological process that occurs after tissues become supersaturated with nitrogen or other alternative gas used to dilute O 2 in breathing gas during deep-sea diving, high-altitude aviation, and space exploration. Although it is widely accepted that gas bubbles are an inciting factor for DCS, most decompression procedures generate asymptomatic blood-borne bubbles, thus prompting a search for additional factors (2, 6, 7) . There is now considerable precedence that microparticles (MPs), cell-derived membrane vesicles with diameters of 0.1-1.0 m, are elevated in association with simulated as well as bona fide underwater diving (8 -10, 16, 26, 27, 30) . Maneuvers that decrease the incidence of DCS also diminish MP production (8, 9) . Murine studies suggest that MPs play a role in high-pressure gas pathophysiology and possibly with gas bubble nucleation (28, 29, 31, 32) . In the mouse model, MPs have been shown to initiate a systemic inflammatory process postdecompression that is related to neutrophil activation (28, 29, 31, 32) . Injuries identified in decompressed animals can be recapitulated by injecting decompression-induced MPs into naïve mice (29, 31, 32) .
We hypothesized that injuries in the mouse DCS model can be abrogated by ascorbic acid. Our interest in ascorbic acid was motivated by observations that neutrophils generate MPs when exposed to elevated partial pressures of helium, nitrogen, or argon, even when there is no elevation of O 2 partial pressure beyond that associated with ambient air (25) . This occurs because of oxidative stress initiated by singlet O 2 , which is generated by collision complexes between O 2 and inert gases. Singlet O 2 triggers a cascade of cytoskeletal modifications that generate MPs. These events are inhibited by ascorbic acid, which is an efficient singlet O 2 scavenger but a relatively poor scavenger for more highly reactive oxygen species, nitric oxide (NO·), and related agents such as peroxynitrite (5, 19) .
SCUBA diving causes upregulation of antioxidant genes and elevations of plasma and intracellular antioxidant enzyme levels (1, 3, 11, (21) (22) (23) . In keeping with this perspective, dietary supplementation with ascorbic acid and vitamin E attenuates endothelial dysfunction in human SCUBA divers (13, 14) . There is precedence in other pathological conditions for ascorbic acid-modifying MP responses. Ascorbic acid supplementation can abrogate MP elevations associated with myocardial infarction and congestive heart failure, as well as from stored erythrocytes, presumably because of its antioxidant action (12, 18, 20) . In this study, MPs were characterized, as is standard, by surface expression of antigenic markers from parent cells and were based on annexin V binding because, as MPs are formed, negatively charged phosphatidylserine residues become exposed.
MATERIALS AND METHODS
Materials. Chemicals were purchased from Sigma-Aldrich (St. Louis, MO) unless otherwise noted. Compressed gases were purchased from Air Products and Chemicals (Allentown, PA). Antibodies were purchased from sources as described below.
Animals. All aspects of this study were reviewed and approved by the Institutional Animal Care and Use Committee. C57BL/6J Mice (Mus musculus) were purchased from Jackson Laboratories (Bar Harbor, ME) and housed in the university animal facility. They all received water ad libitum and unless otherwise specified were fed Laboratory Rodent Diet 5001 (PMI Nutritional, Brentwood, MO). This standard diet is based predominantly on animal-derived protein (calories provided by 29.8% protein, 13.4% fat, and 56.7% carbohydrates). As an alternative, some mice were fed a vegetable proteinderived diet (Teklad Global 18% Protein Rodent Diet; Teklad Diets, Madison, WI) (calories provided by 24% protein, 18% fat, and 58% carbohydrate). Neither diet contains ascorbic acid as a supplement. Among mice fed either diet for a span of 4 wk, there were no statistically significant differences in body weight or blood glucose. Those fed the animal protein diet weighed 28.1 Ϯ 1.4 g (means Ϯ SE, n ϭ 6), and blood glucose was 155.2 Ϯ 5.2 mg/dl; whereas those fed the vegetable protein diet weighed 28.7 Ϯ 2.7 g (n ϭ 9, NS), and blood glucose was 150.1 Ϯ 11.5 (NS) mg/dl.
Mice were left to breathe room air (control) or subjected to 2-h exposure to 790-kPa air exactly as described in previous publications (28, 32) . Some mice were injected with a sterile solution of 500 mg/kg ascorbic acid intraperitoneally 1 h before high-pressure exposure or immediately following decompression. At 2 or 13 h after decompression, animals were anesthetized and euthanized for blood and tissue collection as described previously (28, 32) .
Standard procedures for MP isolation. All reagents and solutions used for MP isolation and analysis were filtered with 0.1-m filter (EMD Millipore, Billerica, MA). MPs were isolated and prepared for analysis by flow cytometry as previously described (28, 32) . Briefly, heparinized blood was immediately fixed with 100 l/ml Fixation Medium A (Invitrogen, Carlsbad, CA) and centrifuged for 5 min at 1,500 g. EDTA was added to the supernatant to achieve 12.5 mM to prevent MP aggregation. Plasma was centrifuged at 15,000 g for 30 min, and the supernatant was used for MP count and subtype analysis by flow cytometry.
MP analysis. MP supernatant (10 l) was labeled for 30 min at room temperature in the dark with optimized concentrations of the following agents in annexin V binding buffer (BD Pharmingen, San Jose, CA): FITC-conjugated annexin V (BD Pharmingen), R-phycoerythrin (PE)-conjugated anti-CD142 (BD Pharmingen), BV510-conjugated anti-mouse CD31 (BD Pharmingen), allophycocyanin (APC)-conjugated anti-mouse Ter119 (eBioscience, San Diego, CA), eFluor 450-conjugated anti-mouse Ly6G (Gr-1) (eBioscience), and PerCP Cy5.5-conjugated anti-mouse CD41 (BioLegend, San Diego, CA). After the staining, 150 l filtered annexin V binding buffer was added to each sample tube to make the total volume 250 l. Neutrophil activation analysis. Whole fixed blood (100 l) was stained for 30 min at room temperature in the dark with optimized concentrations of the following antibodies: eFluor 450-conjugated anti-mouse Ly6G (Gr-1) and FITC-conjugated anti-myeloperoxidase (MPO) (Abcam, Cambridge, MA), PE-conjugated anti-mouse CD18 (BioLegend), and APC-conjugated anti-mouse CD41 (eBioscience). After the staining, 2 ml PBS was added to dilute each sample tube before analysis, with the cytometer acquisition set to use eFluor 450-conjugated anti-mouse Ly6G as the fluorescence trigger to recognize mouse neutrophils.
Vascular permeability assay. Mice were injected with lysinefixable tetramethylrhodamine-conjugated dextran (2 ϫ 10 6 Da, Invitrogen) and endothelium-enriched tissue homogenates prepared using colloidal silica following published methods (28, 32) . Vascular permeability, quantified as perivascular dextran uptake in the experimental group, was normalized to a value obtained with a control mouse included in each experiment.
Ascorbate assay. Plasma ascorbate concentration was measured with a commercially prepared enzyme-coupled assay kit (Cayman Chemical, Ann Arbor, MI) following manufacturer's instruction. Briefly, heparinized blood was centrifuged at 1,000 g for 10 min at 4°C immediately after collection. The top yellow plasma layer was pipetted off without disturbing the white buffy layer. The 800 l of methanol/water/diethylenetriaminepentaacetate (90:7.5:2.5) was added to 200 l plasma on ice for 10 min to precipitate the proteins. After centrifuge at 12,000 g for 10 min at 4°C, the supernatant was collected and stored on ice for analysis or frozen at Ϫ80°C for future analysis.
Statistical analysis. We used Sigmastat software (Systat, Point Richmond, CA) for the statistical analysis. All results were expressed as means Ϯ SE (n ϭ number of mice studied). Neutrophil activation, capillary leak, and annexin V-positive particle counts and subtypes were analyzed by two-way ANOVA with the Holm-Sidak post hoc method for multiple comparisons to evaluate both the impact of pressure/decompression and time from decompression.
RESULTS
MP elevations subsequent to pressurization. The impact of exposure to 790-kPa air pressure for 2 h on circulating annexin V-positive MP number and the effect of ascorbic acid are shown in Fig. 1 . Statistically significant MP elevations were found at 2 and 13 h postdecompression. Ascorbic acid administration itself, that is, in mice that were not subjected to pressure/decompression caused no significant change in MPs counts, and there was no significant elevation at 2 h postdecompression in mice that received ascorbic acid before pressure exposure. Statistically significant elevations were found at 13 h postdecompression in mice who received ascorbic acid prophylactically and in those injected with ascorbic acid immediately after the 2-h pressure exposure.
MP surface protein expression patterns. MP subtypes were characterized by surface markers for vascular cell proteins. Significant differences vs. the MPs in air-exposed control mice were found for all MP subtypes at 13 h after decompression, but elevations were not identified among decompressed mice that received ascorbic acid either prophylactically or following decompression (Fig. 2) . AA-5h, mice injected with ascorbic acid and killed 5 h later (n ϭ 5); AA-16h, mice injected with ascorbic acid and killed 16 h after injection (n ϭ 5); Deco-2h, mice exposed to 790-kPa air pressure for 2 h and killed 2 h postdecompression (n ϭ 6); Deco-13h, mice exposed to 790-kPa air pressure for 2 h and killed 13 h postdecompression (n ϭ 7); AA ϩ Deco 2h, mice injected with ascorbic acid 1 h before exposure to 790-kPa air pressure for 2 h and then killed 2 h postdecompression (n ϭ 6); AA ϩ Deco-13h, mice injected with ascorbic acid 1 h before exposure to 790-kPa air pressure for 2 h and then killed 13 h postdecompression (n ϭ 7); Deco-AA-13h, mice exposed to 790-kPa air pressure for 2 h then injected with ascorbic acid and killed 13 h postdecompression (n ϭ 4). Values are means Ϯ SE, *P Ͻ 0.05, significantly different from control.
Neutrophil activation. Neutrophils were identified as Ly6G-positive cells, and surface expression of MPO and the CD18 component of ␤ 2 -integrins were assessed as indices of neutrophil activation. Surface expression of the platelet-specific protein CD41 was also measured to assess neutrophil-platelet interactions. Neutrophil activation and platelet-neutrophil interactions were present 2 and 13 h after decompression, and these changes were not observed in mice that had received ascorbic acid prophylactically or when administered following decompression (Fig. 3) . Ascorbic acid injections alone had no significant effect on neutrophils.
Vascular permeability. Vascular permeability to rhodaminelabeled dextran was significantly elevated in all tissues (omentum, skeletal muscle, psoas, and brain) at 2 and 13 h after decompression (Fig. 4) . Permeability was not significantly different from control when mice were injected with ascorbic acid before pressure exposure. In mice that received ascorbic acid after decompression, significant elevations in vascular leakage were observed in brain and skeletal muscle but not omentum or psoas.
Ascorbic acid concentration in plasma. The ascorbic acid concentration in plasma of control mice was 48.4 Ϯ 3.3 M (n ϭ 11), and values were not statistically significantly different after decompression. At 2 h after decompression, the concentration was 54.4 Ϯ 6.0 M (n ϭ 6), and at 13 h, it was 39.5 Ϯ 6.1 M (n ϭ 5). If mice were injected with ascorbic acid and the plasma level measured 5 h later (timed to match mice euthanized at 2 h after decompression), the concentration was 242.6 M (n ϭ 5, P ϭ 0.001 vs. control), and at 16 h after injection, it was 252.03 M (n ϭ 4, P Ͻ 0.001). Plasma levels among mice injected with ascorbic acid before being subjected to pressure/decompression exhibited significant reductions in plasma ascorbic acid levels compared with those injected that were then simply left exposed only to air. At 2 h after decompression, the mice that had been injected with ascorbic acid had a plasma level of 91.7 Ϯ 5.5 M (n ϭ 9, P Ͻ 0.05) and 51.6 Ϯ 4.9 M at 13 h after decompression (n ϭ 4, P Ͻ 0.05). In mice injected with ascorbic acid after decompression and euthanized 13 h later, the plasma level was 45.4 Ϯ 4.7 M (n ϭ 4).
Vegetarian diet. A final portion of this study was to evaluate whether changing diet might alter responses to decompression. This study was prompted because the laboratory diet normally used for these studies was based on animal protein, and several human studies have shown that plasma ascorbic acid levels are higher when eating a vegetable-based diet (17, 24) . If mice were fed a vegetable-based protein diet for at least 3 wk, the plasma ascorbic acid concentration was 71.4 Ϯ 10.5 M (n ϭ 3, P Ͻ 0.05 vs. animal protein diet control), and circulating MPs numbered 108 Ϯ 15 (n ϭ 4, P Ͻ 0.05 vs. animal protein diet control). If vegetable-based diet-fed mice were subjected to decompression stress and euthanized 2 h later, plasma ascorbic acid was 73.7 Ϯ 13 M (n ϭ 3, NS vs. air-onlyexposed mice), and there was a significant elevation of MPs to 227 Ϯ 45 (n ϭ 4); however, this value was only about one-tenth that seen in mice fed an animal protein diet (P Ͻ 0.01, Fig. 1 ). These decompressed mice exhibited no significant capillary leak (data not shown). There was evidence of modest neutrophil activation based on CD18 expression but not MPO and no indication of platelet-neutrophil interactions. Expressed as the fold difference from vegetable protein diet-fed control mice, neutrophils from mice subjected to decompression and euthanized 2 h later had surface MPO 1.34 Ϯ 0.58-fold (n ϭ 3, NS) higher than control, a CD18 level 2.28 Ϯ 0.41-fold (n ϭ 3, P ϭ 0.035) higher, and CD41 0.94 Ϯ 0.29-fold (n ϭ 3, NS) higher than that of control mouse neutrophils.
DISCUSSION
Results from this study indicate that ascorbic acid administration can inhibit MP elevations, neutrophil activation, and vascular injury in the murine decompression model. More broadly, it supports the notion that MP production is an oxidative stress response, consistent with several other studies (25, 29, 31, 32 ). There is substantial evidence based on more traditional indices that oxidative stress occurs with SCUBA diving (1, 3, 11, 21-23 ).
There were elevations in total MP number at 13 h postdecompression in mice given ascorbic acid prophylactically, as well as those treated postdecompression. Although recent studies show that MP production occurs during high-pressure exposure, and thus would be most likely to be abrogated with prophylactic ascorbic acid administration, there is progressive MP production, inflammation, and vascular injury postdecompression (25, 26, 28) . Prophylactic administration of ascorbic acid was effective for inhibiting neutrophil activation and all vascular injuries, but administration following decompression was only partially protective. Although less effective, some benefit to postdecompression ascorbic acid treatment is consistent with the time course for inflammation and vascular injuries in previous studies.
The sites where diving-related oxidative stress arises are not fully elucidated. Clearly, neutrophils can be a source (25) . Postdecompression MPs bear proteins derived from neutrophils (Ly6G), platelets (CD41), erythrocytes (Ter119), CD142, which may come from endothelial cells, monocytes, macrophages, and platelets, as well as CD31, which is highly expressed at endothelial cell intercellular junctions but also found on the surface of platelets, monocytes, neutrophils, and some types of T-cells. Because MPs interact and share surface proteins, finding various proteins on particles does not mean that MPs bearing a particular marker were all derived from a single cell source (26, 27, 31, 32 ). The plasma ascorbic acid concentrations among mice receiving intraperitoneal supplementation and then subjected to decompression were significantly lower than the levels in mice that were injected but then simply left exposed only to ambient air. However, among mice that did not get supplementations, there were no significant differences in plasma ascorbic acid concentration between control and decompressed mice. The reason for the discrepancy between unsupplemented and ascorbic acid-supplemented decompressed mice is unclear. Detectable ascorbic acid can decrease because of oxidation, but there is no precedence for considering that its bioavailability would differ in supplemented mice (4, 15) . The assay for vascular leakage used in this study involves dextran with a relatively high molecular weight (2 ϫ 10 6 Da), and thus a more modest vascular injury would go undetected. However, if the decrease in supplemented mice were attributable to vascular extravasation, we would have expected some decrease in the unsupplemented decompressed mice. It is possible that loss was attributable to occult renal injury in decompressed mice and only detected when supraphysiological plasma ascorbic acid levels are present. This issue will require further investigation.
Our observation that MP elevations, most indices of neutrophil activation, and vascular leak can be abrogated by a vegetarian diet is intriguing, but obviously we cannot conclude that the sole effect of the dietary change was on plasma ascorbic acid concentration. The results do offer a heretofore unrecognized reason why variability may occur among animal models and also poses the possibility that responses in human divers may vary with dietary habits. Indeed, the baseline as well as postdecompression MP numbers in vegetarian diet-fed mice are the lowest values we have seen in any of our studies on this subject. The ability to modify high-pressure/decompression MP elevations and associated changes with ascorbic acid offers the novel perspective that DCS may be precipitated by an oxidative injury. A definitive causal relationship between MPs and DCS in humans is, however, still lacking. Whether antioxidants may provide meaningful protection from provocative decompression can be tested in future work.
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